• About
    • Overview
    • Leadership
  • Area of Focus
    • Congestion in Heart Failure
    • Outpatient Parenteral Antimicrobial Treatment (OPAT)
  • Products, Research & Development
    • FUROSCIX® (furosemide injection) 80mg/10mL for subcutaneous use
    • scCeftriaxone
    • Clinical Development & Medical Affairs
  • Investor Relations
    • Investor Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
    • Financial Information
      • Sec Filings
    • News & Events
      • News Releases
      • Event Calendar
      • Presentations
    • Investor Resources
      • Investor FAQ
      • Information Request
      • E-mail Alerts
      • IR Contacts
    • ESG
  • Media Resources
  • Careers
  • Contact Us
  • Legal
    • Privacy Policy
    • Terms of Use
scPharmaceuticals

John Mohr, Pharm.D., FIDP

Feb 28, 2019

John Mohr, Pharm.D., FIDP

Senior Vice President, Clinical Development and Medical Affairs

Mike Hassman

Senior Vice President, Technical Operations

Rachael Nokes

Chief Financial Officer

Oct 26, 2017

John H. Tucker

President and Chief Executive Officer

scPharmaceuticals

scPharmaceuticals is a pharmaceutical company focused on developing and commercializing innovative solutions to enhance the potential of outpatient care.

© 2022 scPharmaceuticals, Inc. All rights reserved. Privacy Policy Terms of Use

Contact

2400 District Avenue, Suite 310
Burlington, MA 01803
617-517-0730
info@scpharma.com

menu

  • About
  • Areas of Focus
  • Products, Research & Development
  • Investor Relations
  • Media Resources
  • Careers
  • Contact Us
scPharmaceuticals
© 2020 scPharmaceuticals, Inc. All rights reserved. Privacy Policy Terms of Use
x

Warning you are leaving this site

You are now leaving the scPharmaceuticals Inc. Corporate Website.